Rosas M, Pastelín G, Lomelí C, Mendoza-González C, Méndez A, Lorenzo-Negrete JA, Martínez-Reding J, Férez SSM, Attie F

Language: Spanish
References: 7
Page: 94-97
PDF size: 85.65 Kb.

ABSTRACT

The incidence of hypertension in the geriatric population is very high and is a significant determinant of cardiovascular risk in this group. The tendency for blood pressure to increase with age in westernized societies such as the United States may depend on environmental factors such as diet, stress, and inactivity. Our population tends to become more obese; to consume relatively greater amounts of sodium and lesser amounts of potassium, calcium, and magnesium; and to decrease exercising with increasing age. Senescent changes in the cardiovascular system leading to decreased vascular compliance and decreased baroreceptor sensitivity contribute not only to rising blood pressure but also to an impairment of postural reflexes and orthostatic hypotension. The hallmark of hypertension in the elderly is increased vascular resistance. Greater vascular reactivity in the elderly hypertensive patients may reflect decreased membrane sodium pump activity and decreased beta-adrenergic receptor activity as well as age-related structural changes. Treatment of diastolic hypertension in the elderly is associated with decreased cardiovascular morbidity and mortality. Although treatment of systolic hypertension may not decrease immediate cardiovascular mortality, it appears to decrease the incidence of stroke. The initial therapeutic approach to the elderly hypertensive patient should generally consist of a reduction in salt and caloric intake and an increase in aerobic exercise, i.e., walking. Drug therapy should be initiated with lower doses of medication with a special concern about orthostatic hypotension.

REFERENCES

1. Thorogood M, Connor Myles, Stephen Tollman, Lewando-Hundt G, et al: A cross-sectional study of vascular risk factors in a rural South African population: data from the Southern African Stroke Prevention Initiative (SASPI). BMC Public Health 2007; 326: 2458-7-326-

2. Franklin SS: Arterial Stiffness: Is It Ready for Prime Time? Curr Cardiol Rep 2007; 9: 462-469.

3. Inoue R, Ohkubo T, Kikuya M, Metoki M, Asayama K, Obara T, Hirose T, Hara A, Hoshi H, Hashimoto J: Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama Study 2007; 20: 1125-1131.

4. Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, de Leeuw PW, et al: On-treatment diastolic blood pressure and prognosis in systolic Hypertension. Arch Intern Med 2007, in press.

5. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP: INDANA Project Steering Committee. Individual Data Analysis of Antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual patient data. Ann Intern Med 2002; 136: 438-448.

6. Fagard RH, Van den Enden M, Leeman M, Warling X: Survey on treatment of hypertension and implementation of WHO-ISH risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297-1302.

7. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A: SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886.